IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
The Gastric Cancer Foundation: A Gastric Cancer Registry
This study is currently recruiting participants.
Verified August 2017 by Stanford University
Sponsor:
Stanford University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01514045
First received: January 17, 2012
Last updated: August 8, 2017
Last verified: August 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer via an online questionnaire with genomic data obtained from blood and tissue samples. The purpose of this registry is to gain better understanding of the causes of gastric cancer, both environmental and genetic; whether certain genomic data can predict outcomes of treatment and survival; as well as explore the issues that effect the quality of life of these patients after diagnosis and treatment.
| Condition |
|---|
| Gastric Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Cross-Sectional |
| Official Title: | The Gastric Cancer Foundation: A Gastric Cancer Registry |
Resource links provided by NLM:
Further study details as provided by Stanford University:
Primary Outcome Measures:
- Collect detailed clinical and epidemiological information on patients with gastric tumors [ Time Frame: A quality of life questionnaire will also be administered when patients first enroll in the registry and then every 6 months after for five years. Specimen collected once. ]
Biospecimen Retention: Samples With DNA
Blood samples with DNA Paraffin embedded tissue will be stored in the Stanford Tissue Bank for 100 years.
| Estimated Enrollment: | 500 |
| Study Start Date: | April 2011 |
| Estimated Study Completion Date: | December 2021 |
| Estimated Primary Completion Date: | December 2020 (Final data collection date for primary outcome measure) |
Collect detailed clinical and epidemiological information on patients with gastric tumors via an online registry and a detailed patient questionnaire. Participants can opt in to contribute a blood sample and paraffin block samples from previous surgery.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Participants will be identified for recruitment either by the individual's treating physician or through information about the registry on the Gastric Cancer Fund website. Potential participants will be directed to the URL for the gastric cancer registry and asked to complete a brief registration form which will include eligibility questions.
Criteria
Inclusion Criteria:
- Patients are eligible if they have a histologically proven gastric tumor including gastroesophageal tumors
- 18 years of age or older
- Adequate English proficiency to complete online consent and questionnaire.
Exclusion Criteria:
- Under 18 years of age
- No history of gastric cancer or gastric cancer in a family member.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01514045
Please refer to this study by its ClinicalTrials.gov identifier: NCT01514045
Contacts
| Contact: Meredith Mills | 650-724-5223 | bluett@stanford.edu |
Locations
| United States, California | |
| Stanford University, School of Medicine | Recruiting |
| Stanford, California, United States, 94305 | |
| Contact: Meredith Mills 650-724-5223 bluett@stanford.edu | |
| Principal Investigator: James M Ford, MD | |
| Sub-Investigator: Hanlee P Ji, MD | |
Sponsors and Collaborators
Stanford University
Investigators
| Principal Investigator: | James M Ford, MD | Stanford University |
More Information
| Responsible Party: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT01514045 History of Changes |
| Other Study ID Numbers: |
GI0005 SU-01172012-8987 ( Other Identifier: Stanford University ) 20285 ( Other Identifier: Stanford University ) |
| Study First Received: | January 17, 2012 |
| Last Updated: | August 8, 2017 |
Keywords provided by Stanford University:
|
Quality of Life |
Additional relevant MeSH terms:
|
Stomach Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Stomach Diseases |
ClinicalTrials.gov processed this record on September 19, 2017